LOOMIS SAYLES & CO L P – CRISPR Therapeutics AG Transaction History
LOOMIS SAYLES & CO L P portfolio value:
$81.37M
portfolio value
LOOMIS SAYLES & CO L P quarter portfolio value change:
+7.54%
quarter
CRISPR Therapeutics AG 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -10.82% | -151.05K shares | -3.47M | $65.35 | 1.24M |
| Q2 2022 | share | Increase | +8.16% | 105.35K shares | 3.82M | $60.77 | 1.39M |
| Q1 2022 | share | Decrease | -1.92% | -25.21K shares | -18.70M | $62.77 | 1.29M |
| Q4 2021 | share | Increase | +42.14% | 390.20K shares | -3.90M | $78.85 | 1.31M |
| Q3 2021 | share | Increase | +1.90% | 17.26K shares | -43.46M | $111.93 | 925.91K |
| Q2 2021 | share | Increase | 0.00% | 908.65K shares | 147.10M | $161.89 | 908.65K |